Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

759368

	registered interest
	date	11/09/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prostate Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that men are able to access early prostate tests.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	10002
	answer	answer is ministerial correction date of answer 18/09/2017 answer text <p>The National Health Service Prostate Cancer Risk Management Programme (PCRMP) provides general practitioners and primary care professionals with information to counsel men who ask about prostate cancer and/or prostate-specific antigen (PSA) testing. Men over 50 who decide to have a PSA test based on this information can do so for free on the NHS.</p><p>The PCRMP information pack was revised and updated in March 2016 and is available at the following link:</p><p><a href="http://www.gov.uk/guidance/prostate-cancer-risk-management-programme-overview" target="_blank">www.gov.uk/guidance/prostate-cancer-risk-management-programme-overview</a></p><p>The PCRMP has also produced information leaflets that healthcare professionals can use when discussing the test with eligible men, which are available at the following link.</p><p><a href="http://www.gov.uk/government/collections/prostate-cancer-risk-management-programme-supporting-documents" target="_blank">www.gov.uk/government/collections/prostate-cancer-risk-management-programme-supporting-documents</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/09/2017 13:33:03 answering member 4067 label Biography information for Steve Brine
	tabling member	4131 label Biography information for Jim Shannon

798639

	registered interest
	date	01/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prostate Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when the SelectMDx urine test for prostate cancer will be made available on the NHS.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	117033
	answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>The future availability of any new or novel tests on the National Health Service, such as the SelectMDx test for prostate cancer, would be subject to large scale clinical trials demonstrating the safety and efficacy of the diagnostic approach and subsequent assessments of its cost effectiveness for routine use.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:47:34 answering member 4067 label Biography information for Steve Brine
	tabling member	4131 label Biography information for Jim Shannon

850994

	registered interest
	date	27/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prostate Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of (a) the potential number of cases of prostate cancer which could be identified earlier by a national prostate cancer screening programme and (b) the potential effect such a programme on survival rates.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	130192
	answer	answer is ministerial correction date of answer 07/03/2018 answer text <p>The United Kingdom National Screening Committee (UK NSC) last reviewed the evidence about screening for prostate cancer in 2016. Evidence showed that prostate screening can reduce prostate cancer deaths by 27% of the 10,000 lives lost in the UK annually to prostate cancer. No assessment has been made on the potential number of cases identified earlier by a screening programme.</p><p>The Committee recommended against a population screening programme. The reasons for this included that the test which is available for use in screening, Prostate-Specific Antigen (PSA), is neither very specific nor very sensitive, and is unable to distinguish between slow-growing and fast-growing cancers; there is therefore a risk that a national screening programme would lead to a high number of false positives. There are major harms of treating men who incorrectly test positive (i.e. have false positive tests), these include impotence, incontinence and rectal problems.</p><p>The UK NSC will be reviewing the evidence to screen for prostate cancer later in 2018/19. More information will be available at:</p><p><a href="https://legacyscreening.phe.org.uk/prostatecancer" target="_blank">https://legacyscreening.phe.org.uk/prostatecancer</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/03/2018 10:10:59 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

856222

	registered interest
	date	06/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prostate Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many men have been screened for prostate cancer in each Clinical Commissioning Group area in each year of the last five years.
	tabling member constituency	Halton
	tabling member printed	Derek Twigg
	uin	131388
	answer	answer is ministerial correction date of answer 12/03/2018 answer text <p>Prostate screening is not offered as a population screening programme in the United Kingdom.</p><p> </p><p>The UK National Screening Committee (UK NSC) last reviewed the evidence about screening for prostate cancer in 2016 and recommended against a population screening programme. The reasons for this included that the test which is available for use in screening, Prostate-Specific Antigen, is neither very specific nor very sensitive, and is unable to distinguish between slow-growing and fast-growing cancers; there is therefore a risk that a national screening programme would lead to a high number of false positives. There are major harms of treating men who incorrectly test positive (i.e. have false positive tests), these include impotence, incontinence and rectal problems.</p><p> </p><p>The UK NSC will be reviewing the evidence to screen for prostate cancer later in 2019/20. More information is available at:</p><p> </p><p><a href="https://legacyscreening.phe.org.uk/prostatecancer" target="_blank">https://legacyscreening.phe.org.uk/prostatecancer</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/03/2018 17:03:49 answering member 4067 label Biography information for Steve Brine
	tabling member	429 label Biography information for Derek Twigg

860687

	registered interest
	date	12/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prostate Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that all men over 50 year of age have access to prostate tests even when they have no symptoms of prostate cancer.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	132044
	answer	answer is ministerial correction date of answer 20/03/2018 answer text <p>Prostate screening is not offered as a population screening programme in the United Kingdom.</p><p> </p><p>The UK National Screening Committee (UK NSC) last reviewed the evidence about screening for prostate cancer in 2016 and recommended against a population screening programme. The reasons for this included that the test which is available for use in screening, Prostate-Specific Antigen, is neither very specific nor very sensitive and is unable to distinguish between slow-growing and fast-growing cancers; there is therefore a risk that a national screening programme would lead to a high number of false positives. There are major harms of treating men who incorrectly test positive (i.e. have false positive tests), these include impotence, incontinence and rectal problems.</p><p> </p><p>The UK NSC will be reviewing the evidence to screen for prostate cancer later in 2019/20. More information is available at the following link:</p><p> </p><p><a href="https://legacyscreening.phe.org.uk/prostatecancer" target="_blank">https://legacyscreening.phe.org.uk/prostatecancer</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/03/2018 10:51:41 answering member 4067 label Biography information for Steve Brine
	tabling member	4131 label Biography information for Jim Shannon

933812

	registered interest
	date	02/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prostate Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve testing procedures for prostate cancer.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	159601
	answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>The Prostate Specific Antigen (PSA) test measures the level of PSA in a man’s blood, and is currently the most common method of identifying an increased risk of localised prostate cancer. There have been efforts in recent years to develop risk prediction tools that use different blood tests (biomarkers) and other characteristics (e.g. size of the prostate, age etc) in addition to PSA to assess more accurately whether a man has clinically significant prostate cancer.</p><p>The United Kingdom National Screening Committee (UK NSC) can be alerted to the publication of any new peer-reviewed evidence which suggests a change in the current recommendation, such as a new test, via the UK NSC’s early update process. Submissions are accepted throughout the year.</p><p>More information on how an early update can be submitted to the UK NSC for consideration is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/uk-nsc-evidence-review-process/uk-nsc-evidence-review-process" target="_blank">https://www.gov.uk/government/publications/uk-nsc-evidence-review-process/uk-nsc-evidence-review-process</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/07/2018 15:34:45 answering member 4067 label Biography information for Steve Brine
	tabling member	4131 label Biography information for Jim Shannon